Vitamin Well Raises $2.2bn for EMPWR Deal

Transaction Overview

Vitamin Well AB, a Swedish beverage company, arranged a cross‑currency loan facility of approximately $2.2 billion to finance its acquisition of EMPWR Nutrition Group, a protein‑bar manufacturer.

Loan Structure

The facility comprises three tranches:

• A US‑dollar tranche of $1 billion issued at 99 cents on the dollar.
• A euro‑denominated tranche of €890 million (approximately $1 billion) issued at 99.5 cents on the euro.
• A Swedish‑krona tranche of 1.55 billion SEK (about $160 million).

Both the USD and euro tranches were priced 3.5 percentage points above their respective benchmark rates, placing the pricing at the tight end of the initial price talk.

Arrangers

Barclays Plc, Citigroup Inc and UBS Group AG acted as joint arrangers for the transaction.

Use of Proceeds

All loan proceeds are earmarked to fund the purchase of EMPWR Nutrition Group.